PET / CT With 18F-FDG: Does it Optimize the I 123-MIBG Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator?
PET / CT With 18F-FDG (18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography): Does it Optimize the I 123-MIBG (Iodine 123 Metaiodobenzylguanidine) Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator for Primary Prevention in Patients With Heart Failure of Ischemic Origin?
Sponsor: Centre Hospitalier Universitaire de Nīmes
Terminated
Inclusion rate too slow / infeasible.
Other terminated trials from Centre Hospitalier Universitaire de Nīmes
- Colorectal Cancer Metastatic · Phase NA · Oct 2025
- Deep Vein Thrombosis (DVT)/Thrombophlebitis · Feb 2025
- Atrial Fibrillation · Phase NA · Dec 2024
- Acute Kidney Injury · Phase PHASE3 · Dec 2024
- Rheumatoid Arthritis · Phase NA · Sep 2024
See all terminations from Centre Hospitalier Universitaire de Nīmes
Other Defibrillators, Implantable trials with similar outcome
Listed as NCT01258283, this observational or N/A phase trial focuses on Defibrillators, Implantable and remains terminated or withdrawn. Sponsored by Centre Hospitalier Universitaire de Nīmes, it has been updated 7 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Jun 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Nīmes
For direct contact, visit the study record on ClinicalTrials.gov .